跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,746 条关于
“Merz Pharma GmbH & Co KgaA”
全部
21,746
临床试验
6,816
药物
2,184
机构
3,273
资讯
9,473
3个月前
Teijin and Merz Secure Japanese Approval for XEOMIN® in Cervical Dystonia and Blepharospasm
去年
Global Cerebral Palsy Clinical Trial Landscape Assessed in New 2024 Review
去年
XEOMIN Receives First-Ever Approval in Japan for Chronic Sialorrhea Treatment
3个月前
Merz Therapeutics Partners with Kvvit to Bring INBRIJA Parkinson's Treatment to Greater China
上个月
Analysts Maintain Buy Ratings on Fresenius SE & Co. KGaA Amid Positive Insider Sentiment
去年
TBI Therapeutics Advance Through Clinical Trials: SanBio's SB623 Receives Sakigake Designation
5个月前
German Court Grants Sales Ban for Generic Fampridine Products Following Patent Victory for Merz
昨天
Merz Therapeutics Wins EU/EEA Approval for Xeomin in Pediatric Pes Equinus Spasticity
去年
Clarity Pharma Shares Surge on Production Deal with Nucleus Radiopharma for Prostate Cancer Drug
去年
Reviva Pharmaceuticals' Brilaroxazine Shows Positive Phase 3 Results for Schizophrenia Treatment
第 1 页，共 948 页
上一页
下一页
